Cardiovascular Safety of Exenatide Once Weekly (Type 2 Diabetes)

Effects of four classes of drugs in combination with metformin for the treatment of type 2 diabetes.

Iron reduction by blood donation for the prevention and treatment of type 2 diabetes

PF-04634817 is a chemokine CCR2/5 receptor antagonist that is being developed for the treatment of diabetic nephropathy